Onderneming Medicenna Therapeutics Corp.
Aandelen
MDNA
CA58490H1073
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,64 CAD | -1,80% | -16,33% | +290,48% |
Vakgebied
Aantal werknemers: 16
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Founder | - | 01-10-11 | |
Fahar Merchant
CEO | Chief Executive Officer | - | 02-02-15 |
David Hyman
DFI | Director of Finance/CFO | - | 14/02 |
Delphine Davan
IRC | Investor Relations Contact | - | 14-08-23 |
Minh To
PRN | Corporate Officer/Principal | - | 14-08-23 |
Eamonn Peters
PRN | Corporate Officer/Principal | - | 14-08-23 |
Evelyn Pau
PRN | Corporate Officer/Principal | - | 14-08-23 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Karen Dawes
BRD | Director/Board Member | 72 | 24-09-19 |
Albert Beraldo
BRD | Director/Board Member | - | 22-11-16 |
Fahar Merchant
CEO | Chief Executive Officer | - | 02-02-15 |
Founder | - | 01-10-11 | |
Jack Geltosky
BRD | Director/Board Member | 78 | 30-09-20 |
John Sampson
BRD | Director/Board Member | - | 23-09-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 69 637 469 | 48 558 694 ( 69,73 %) | 0 | 69,73 % |
Bedrijfsgegevens
Sector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+290,48% | 84,58 mln. | |
-1,42% | 41,35 mld. | |
+42,15% | 40,38 mld. | |
+1,97% | 39,05 mld. | |
-14,19% | 26,67 mld. | |
+1,82% | 24,07 mld. | |
-24,55% | 18,36 mld. | |
-4,07% | 11,68 mld. | |
+21,36% | 11,6 mld. | |
+8,20% | 11,15 mld. |
- Beurs
- Aandelen
- Koers MDNA
- Onderneming Medicenna Therapeutics Corp.